Inebilizumab, CAS [[1299440-37-1]]

Produktübersicht

• Artikelname: Inebilizumab, CAS [[1299440-37-1]]
• Artikelnummer: TGM-T76713
• Hersteller Artikelnummer: T76713
• Alternativnummer: TGM-T76713-1MG,TGM-T76713-5MG,TGM-T76713-10MG,TGM-T76713-25MG,TGM-T76713-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: MEDI 551 , MT-0551 , 16C4-aFuc , VIB-0551

Produktbeschreibung

Inebilizumab is a humanized anti-CD19 monoclonal antibody with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used to treat a range of autoimmune diseases associated with CD19 B cells, such as multiple sclerosis and optic neuromyelitis.

Produkteigenschaften

• Reinheit: 96.20%
• CAS Nummer: [1299440-37-1]
• Target-Kategorie: Immunology/Inflammation related|||ADC Antibody